Todd Hembrough
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 5
- Oncology 17
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Steven L. Gonias (4 shared papers)Li Li (3 shared papers)Adonia E. Papathanassiu (2 shared papers)Shawn J. Green (2 shared papers)Glenn M. Swartz (3 shared papers)Victor S. Pribluda (2 shared papers)Elizabeth B. Kelso (2 shared papers)John C. Lockhart (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Cancer Discovery (3 papers)Molecular Cancer Therapeutics (3 papers)Blood (3 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Todd Hembrough
55 papers receiving 3.6k citations
Todd Hembrough's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 781
- Oncology 1.3k
- Hematology 403
- Pulmonary and Respiratory Medicine 971
- Genetics 246
Countries citing papers authored by Todd Hembrough
This map shows the geographic impact of Todd Hembrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Hembrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Hembrough more than expected).
Fields of papers citing papers by Todd Hembrough
This network shows the impact of papers produced by Todd Hembrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Hembrough. The network helps show where Todd Hembrough may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd Hembrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial Hit paper breakdown → | 2018 | 473 |
| 2 | Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS Hit paper breakdown → | 2017 | 437 |
| 3 | 2020 | 280 | |
| 4 | 2018 | 214 | |
| 5 | Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. | 2003 | 169 |
| 6 | 2006 | 168 | |
| 7 | 2019 | 160 | |
| 8 | 2017 | 138 | |
| 9 | 2018 | 134 | |
| 10 | 2010 | 120 | |
| 11 | 1995 | 110 | |
| 12 | 2018 | 108 | |
| 13 | 1996 | 95 | |
| 14 | 2015 | 75 | |
| 15 | 2007 | 71 | |
| 16 | 2001 | 68 | |
| 17 | 2020 | 64 | |
| 18 | 2020 | 61 | |
| 19 | 2013 | 56 | |
| 20 | 2012 | 55 |
About Todd Hembrough
Todd Hembrough is a scholar working on Cancer Research, Oncology, Cell Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 56 papers that have together received 3.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers), Advanced Proteomics Techniques and Applications (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Cancer Research (781 citations), Oncology (1.3k citations), Hematology (403 citations), Pulmonary and Respiratory Medicine (971 citations) and Genetics (246 citations). Todd Hembrough has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Steven L. Gonias, Li Li, Adonia E. Papathanassiu, Shawn J. Green, Glenn M. Swartz, Victor S. Pribluda, Elizabeth B. Kelso, John C. Lockhart, Lynette Dunning and William R. Ferrell. Their work appears in journals such as Annals of Oncology, Cancer Discovery, Molecular Cancer Therapeutics, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.